These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 14594945)
21. Evaluation of pyrazolopyrimidine derivatives as microtubule affinity regulating kinase 4 inhibitors: Towards therapeutic management of Alzheimer's disease. Naqvi AAT; Jairajpuri DS; Noman OMA; Hussain A; Islam A; Ahmad F; Alajmi MF; Hassan MI J Biomol Struct Dyn; 2020 Aug; 38(13):3892-3907. PubMed ID: 31512980 [TBL] [Abstract][Full Text] [Related]
22. Crystal structure of microtubule affinity-regulating kinase 4 catalytic domain in complex with a pyrazolopyrimidine inhibitor. Sack JS; Gao M; Kiefer SE; Myers JE; Newitt JA; Wu S; Yan C Acta Crystallogr F Struct Biol Commun; 2016 Feb; 72(Pt 2):129-34. PubMed ID: 26841763 [TBL] [Abstract][Full Text] [Related]
23. CDK1-mediated phosphorylation of the RIIalpha regulatory subunit of PKA works as a molecular switch that promotes dissociation of RIIalpha from centrosomes at mitosis. Carlson CR; Witczak O; Vossebein L; Labbé JC; Skålhegg BS; Keryer G; Herberg FW; Collas P; Taskén K J Cell Sci; 2001 Sep; 114(Pt 18):3243-54. PubMed ID: 11591813 [TBL] [Abstract][Full Text] [Related]
24. Microtubule/MAP-affinity regulating kinase (MARK) is activated by phenylarsine oxide in situ and phosphorylates tau within its microtubule-binding domain. Jenkins SM; Johnson GV J Neurochem; 2000 Apr; 74(4):1463-8. PubMed ID: 10737602 [TBL] [Abstract][Full Text] [Related]
26. DAPK activates MARK1/2 to regulate microtubule assembly, neuronal differentiation, and tau toxicity. Wu PR; Tsai PI; Chen GC; Chou HJ; Huang YP; Chen YH; Lin MY; Kimchi A; Chien CT; Chen RH Cell Death Differ; 2011 Sep; 18(9):1507-20. PubMed ID: 21311567 [TBL] [Abstract][Full Text] [Related]
27. Human microtubule affinity-regulating kinase 4 is stable at extremes of pH. Naz F; Singh P; Islam A; Ahmad F; Imtaiyaz Hassan M J Biomol Struct Dyn; 2016 Jun; 34(6):1241-51. PubMed ID: 26208600 [TBL] [Abstract][Full Text] [Related]
28. Protein 4.1R regulates interphase microtubule organization at the centrosome. Pérez-Ferreiro CM; Vernos I; Correas I J Cell Sci; 2004 Dec; 117(Pt 25):6197-206. PubMed ID: 15564380 [TBL] [Abstract][Full Text] [Related]
29. Signaling from MARK to tau: regulation, cytoskeletal crosstalk, and pathological phosphorylation. Timm T; Matenia D; Li XY; Griesshaber B; Mandelkow EM Neurodegener Dis; 2006; 3(4-5):207-17. PubMed ID: 17047359 [TBL] [Abstract][Full Text] [Related]
30. Microtubule affinity-regulating kinase 4: structure, function, and regulation. Naz F; Anjum F; Islam A; Ahmad F; Hassan MI Cell Biochem Biophys; 2013 Nov; 67(2):485-99. PubMed ID: 23471664 [TBL] [Abstract][Full Text] [Related]
31. Role of individual MARK isoforms in phosphorylation of tau at Ser²⁶² in Alzheimer's disease. Gu GJ; Lund H; Wu D; Blokzijl A; Classon C; von Euler G; Landegren U; Sunnemark D; Kamali-Moghaddam M Neuromolecular Med; 2013 Sep; 15(3):458-69. PubMed ID: 23666762 [TBL] [Abstract][Full Text] [Related]
32. Nek11, a new member of the NIMA family of kinases, involved in DNA replication and genotoxic stress responses. Noguchi K; Fukazawa H; Murakami Y; Uehara Y J Biol Chem; 2002 Oct; 277(42):39655-65. PubMed ID: 12154088 [TBL] [Abstract][Full Text] [Related]
33. Dynamic recruitment of Nek2 kinase to the centrosome involves microtubules, PCM-1, and localized proteasomal degradation. Hames RS; Crookes RE; Straatman KR; Merdes A; Hayes MJ; Faragher AJ; Fry AM Mol Biol Cell; 2005 Apr; 16(4):1711-24. PubMed ID: 15659651 [TBL] [Abstract][Full Text] [Related]
34. Identification of a new microtubule-interacting protein Mip-90. González M; Cambiazo V; Maccioni RB Eur J Cell Biol; 1995 Jun; 67(2):158-69. PubMed ID: 7664757 [TBL] [Abstract][Full Text] [Related]
35. An identification of MARK inhibitors using high throughput MALDI-TOF mass spectrometry. Hruba L; Polishchuk P; Das V; Hajduch M; Dzubak P Biomed Pharmacother; 2022 Feb; 146():112549. PubMed ID: 34923338 [TBL] [Abstract][Full Text] [Related]
36. A cell-penetrating peptide derived from SARS-CoV-2 protein Orf9b allosterically inhibits MARK4 activity and mitigates tau toxicity. Oba T; Homma D; Limlingan SJM; Fukuchi A; Asada A; Saito T; Ando K Neurobiol Dis; 2023 Nov; 188():106334. PubMed ID: 37884211 [TBL] [Abstract][Full Text] [Related]
37. Targeting inhibition of microtubule affinity regulating kinase 4 by Harmaline: Strategy to combat Alzheimer's disease. Adnan M; Anwar S; DasGupta D; Patel M; Elasbali AM; Alhassan HH; Shafie A; Siddiqui AJ; Bardakci F; Snoussi M; Hassan MI Int J Biol Macromol; 2023 Jan; 224():188-195. PubMed ID: 36257368 [TBL] [Abstract][Full Text] [Related]
38. Phosphorylation of microtubule-associated proteins MAP2 and MAP4 by the protein kinase p110mark. Phosphorylation sites and regulation of microtubule dynamics. Illenberger S; Drewes G; Trinczek B; Biernat J; Meyer HE; Olmsted JB; Mandelkow EM; Mandelkow E J Biol Chem; 1996 May; 271(18):10834-43. PubMed ID: 8631898 [TBL] [Abstract][Full Text] [Related]
39. Structural variations in the catalytic and ubiquitin-associated domains of microtubule-associated protein/microtubule affinity regulating kinase (MARK) 1 and MARK2. Marx A; Nugoor C; Müller J; Panneerselvam S; Timm T; Bilang M; Mylonas E; Svergun DI; Mandelkow EM; Mandelkow E J Biol Chem; 2006 Sep; 281(37):27586-99. PubMed ID: 16803889 [TBL] [Abstract][Full Text] [Related]
40. Cellular phosphorylation of tau by GSK-3 beta influences tau binding to microtubules and microtubule organisation. Wagner U; Utton M; Gallo JM; Miller CC J Cell Sci; 1996 Jun; 109 ( Pt 6)():1537-43. PubMed ID: 8799840 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]